MIT Technology Review June 10, 2021
Researchers are using analytics and existing patient data to ease recruitment, reduce costs, and accelerate timelines.
Clinical trials have never been more in the public eye than in the past year, as the world watched the development of vaccines against covid-19, the disease at the center of the 2020 coronavirus pandemic. Discussions of study phases, efficacy, and side effects dominated the news. The most distinctive feature of the vaccine trials was their speed. Because the vaccines are meant for universal distribution, the study population is, basically, everyone. That unique feature means that recruiting enough people for the trials has not been the obstacle that it commonly is.
“One of the most difficult parts of my job is enrolling patients into...
Today's Sponsors
Today's Sponsor